AHS
Document Sample


National Cancer Institute
Michael Alavanja, Dr.P.H.
Captain, USPHS
Senior Investigator,
Division of Cancer Epidemiology and
Genetics, NCI
2007 North American Pesticide Applicator
Certification &
Safety Education Workshop
August 20-23, 2007
Portland, Maine
Agricultural Health Study
on Cancer Findings.
Session I: General Strategy
Tuesday, August 21
Breakout Session #1
Do pesticides cause cancer ?
Few strong and consistent associations linking a single
chemical to a single cancer.
Animal/laboratory studies show most pesticides in current
use to be non-genotoxic.
Exposure assessment in previous epidemiologic studies was
general weak, they were based on interviews and could
suffer from case recall bias.
Studies of pesticide manufactures are generally too small to
give meaningful results for cancer
Exposures among the general population in developed
countries are relative low and effect hard to measure.
In summary: Neither animal studies nor human studies give a
compelling case for an association.
Background
World-wide occupational exposures to pesticides
exceed 1.8 billion people (World Bank estimate).
Everyone in the USA has some indirect exposure
to pesticides (NHANES).
Agricultural Insecticides as a group labeled as
probable (group 2A) human carcinogens by
IARC.
Only arsenic and dioxin are listed as human
carcinogens by IARC.
Vital public health need to identify human
carcinogens on the market!
Background
The Occupational & Environmental Epidemiology Branch,
NCI has a history of ecological and case-control of
farmers starting in the 1970’s.
A common critique- exposure assessment was weak.
I proposed the idea for a prospective cohort study of
pesticide applicators in 1989- 1990.
In 1991 an extramural advisory group recommended the
OES conduct the AHS.
The Agricultural Heath Study entered the field in
December 12, 1993.
Other federal partners joined the team in 1994 (EPA), 1995
(NIEHS) and NIOSH (1997).
Design AHS
(www.aghealth.org)
Prospective cohort study of 89,658 pesticide
applicators & spouses (IA and NC).
82% of target population enrolled 1993-1997.
Little loss to follow-up (<2%).
Cancer incidence and mortality updated annually.
Comprehensive exposure assessment information on
82 pesticides collected at three points in time.
Questionnaire exposure assessment evaluated with
field measurements of pesticides.
Buccal cells collected on >35,000 study subjects.
Disease Etiology In the AHS
Central Research Objectives:
1. Characterize exposures to the highest
degree ever achieved in large cohort study.
2. Identify pesticides and other agricultural
exposures that increase the risk of cancer .
3. Identify the mode of action of agents
causing disease.
Types of Pesticide Exposure
Acute exposure events. High exposure dose, short
time period (minutes or hours).
Chronic exposure. Low exposure dose, long time
period (hundreds or thousands of days in a lifetime).
Agricultural Health Study
Pesticide Exposure Estimates
Calculating Cumulative Exposure Index:
Cumulative Exposure = Intensity * Duration
Where:
Intensity = Exposure scores obtained from algorithms
Duration = Days/years * Years/life-time = days/life-time
From: Dosemeci et al. Ann Occup Hyg 46:245-260, 2002.
CONCENTRATIONS IN POST-APPLICATION
URINE - GEOMETRIC MEAN (ug/L)
70 No Gloves
Cab No
60 Gloves
50 No Gloves
No Cab
40
ug/L
30 Gloves
Gloves
Gloves Cab
20 No Cab
No Cab
Cab
10
0
Boom Spray In-Furrow Hand Spray
Questionnaire Evaluation: Monitoring Visits
Study Subjects IA NC Total
Pesticide
Applicators
(dermal, 84 23 107
inhalation and
urine)
Spouses (urine) 38 11 49
Children (urine) 9 3 12
Questionnaire Evaluated with Field
Measurements of 2,4-D and Other Pesticides
Technician
observations MLA Questionnaire
Day 1 } Day 2 Day 3&4
Mix Load Apply (MLA).
1. Hand wipes after MLA Collect full first morning void
2. Dermal patches
3. Air measurements
3. Collect each void from MLA
through next morning void.
Collect full first morning void
Comparison of Questionnaire Based Intensity
Scores and Field Measurements 2,4-D
(Thomas et al., in review)
Intensity Score Urine
Mean Concentration
(Range) Ug/L
low
13
5.5
(2.5-170)
(3.0-7.2)
Medium
19
9.4
(2.5-180)
(8.4-11.2)
High
52
15.2
(1.6-970)
(12.0-20.0)
N=68
R=0.6 p<0.001
Conclusions:
From Exposure Algorithm Assessment
For 2,4-D applicators we observed a
significant correlation between the
questionnaire-based algorithm (intensity-
factor) and post-application urine
concentrations.
Important additional determinants of
exposure have been identified to refine the
exposure algorithm.
Evaluating the association
between estimated
exposures with health effects.
(Cancer Etiology Studies in the
AHS)
Effect
End point of a causal mechanism.
Amount of change in a population’s disease
frequency caused by a specific factor.
Incident rate: Number of new cases of disease in a
specified period of time.
Absolute effect: I1 – I0
Relative Effect: I1 / I0
Confounding factors
A confounding factor must be a risk factor for the
disease.
A confounding factor must be associated with the
exposure under study in the source population (the
population from which the cases are derived).
A confounding factor must not be effected by the
exposure or the disease. In particular, it cannot be
an intermediate step in the causal path between the
exposure and the disease.
How do we control confounding? Collect
quantitative information on the exposure to the
confounder and add the term to the multivariate
model: y=b0 + b1x1 + b2 x2
Statistical Interaction-Effect
Modification
An effect-modifier is an exposure or host factor that
modulates the extent of the effect of the study
variable on the disease under investigation.
If a cohort is divided into two or more distinct
categories defined by the level of an effect modifier
the stratum-specific effect measures may or may not
be equal. If they are equal there is no effect
modification. If they are significantly different there
is effect modification.
How do measure effect modification? Collect
quantitative information on the exposure thought to
be an effect modifier and add the product term to
the multivariate model: y=b0 + b1x1 + b2 x2 + b 3 x1 x2
Typical Sequence of Cancer Etiology
Studies in AHS [2003-2007]
SIR analysis (generates general hypothesis) [n=1]
Nested case-control study of specific cancers
(generate specific hypotheses [n=6])
1 ST COHORT ANALYSIS of specific pesticide
(generates or refines specific hypotheses [n=21])
2ND COHORT ANALYSIS:
(Test Specific Hypotheses [n=1 in progress])
Molecular epidemiology studies of cancer
(Evaluates biological plausibility and mode of action
[n=3 in progress])
AHS Research Strategy:
Mitigate False Positive Results
Biological
Initial Replication Evidence in
Findings later in time Humans
Exposure- Exposure-
Iowa Response Response YES
North Exposure- Exposure-
YES
Carolina Response Response
License Exposure- Exposure-
Type YES
Response Response
Mitigate False-Positive Associations and
Study Rare Diseases
Agricultural Health Cohort
Consortium.
(NCI organized)
Regulatory Implications of AHS Findings
International Agency for Research on
Cancer.
International recommendations
United States Environmental Protection Agency
Educating pesticide applicators
Label instructions
Limitations of use
Banning use
Thank you for listening: AHS Research
Team
Michael Alavanja (PI) Daehee Kang
Laura Beane-Freeman Stella Koutros
Erin Bell Charles Knott (NC field station)
Aaron Blair (Co-PI) Won-Jin Lee
Matthew Bonner Charles Lynch (Univ. IA)
Joseph Coble Shannon Lynch
Brian Curwin (NIOSH) Jay Lubin
Mustafa Dosemeci Rajeev Mahajan
Anne Claire De Ross Mark Purdue
Larry Engel Jennifer Rusiecki
Richard Hayes Claudine Samanic
Cynthia Hines (NIOSH) Rashmi Singha
Jane Hoppin (NIEHS) Dale Sandler (NIEHS)
Lifang Hou Kent Thomas (EPA)
Ann Hsing Our Many Extramural Collaborators
Get documents about "